Fusion Lumbar Vertebral Joint to New Technology Group 7 with Interbody Fusion Device, Custom-Made Anatomically Designed, Open Approach - XRGB0R7
Fusion Lumbar Vertebral Joint to New Technology Group 7 with Interbody Fusion Device, Custom-Made Anatomically Designed, Percutaneous Approach - XRGB3R7
Fusion Lumbar Vertebral Joint to New Technology Group 7 with Interbody Fusion Device, Custom-Made Anatomically Designed, Percutaneous Endoscopic Approach - XRGB4R7
Fusion Lumbar Vertebral Joints, 2 or more to New Technology Group 10 with Facet Joint Fusion Device, Paired Titanium Cages, Open Approach - XRGC0EA
Fusion Lumbar Vertebral Joints, 2 or more to New Technology Group 7 with Interbody Fusion Device, Custom-Made Anatomically Designed, Open Approach - XRGC0R7
Fusion Lumbar Vertebral Joints, 2 or more to New Technology Group 7 with Interbody Fusion Device, Custom-Made Anatomically Designed, Percutaneous Approach - XRGC3R7
Fusion Lumbar Vertebral Joints, 2 or more to New Technology Group 7 with Interbody Fusion Device, Custom-Made Anatomically Designed, Percutaneous Endoscopic Approach - XRGC4R7
Fusion Lumbosacral Joint to New Technology Group 10 with Facet Joint Fusion Device, Paired Titanium Cages, Open Approach - XRGD0EA
Fusion Lumbosacral Joint to New Technology Group 7 with Interbody Fusion Device, Custom-Made Anatomically Designed, Open Approach - XRGD0R7
Fusion Lumbosacral Joint to New Technology Group 7 with Interbody Fusion Device, Custom-Made Anatomically Designed, Percutaneous Approach - XRGD3R7
Fusion Lumbosacral Joint to New Technology Group 7 with Interbody Fusion Device, Custom-Made Anatomically Designed, Percutaneous Endoscopic Approach - XRGD4R7
Fusion Sacroiliac Joint, Right to New Technology Group 8 with Internal Fixation Device with Tulip Connector, Open Approach - XRGE058
Fusion Sacroiliac Joint, Right to New Technology Group 8 with Internal Fixation Device with Tulip Connector, Percutaneous Approach - XRGE358
Fusion Sacroiliac Joint, Left to New Technology Group 8 with Internal Fixation Device with Tulip Connector, Open Approach - XRGF058
Fusion Sacroiliac Joint, Left to New Technology Group 8 with Internal Fixation Device with Tulip Connector, Percutaneous Approach - XRGF358
Fusion Ankle Joint, Right to New Technology Group 9 with Internal Fixation Device, Open-truss Design, Open Approach - XRGJ0B9
Fusion Ankle Joint, Right to New Technology Group 10 with Internal Fixation Device, Gyroid-Sheet Lattice Design, Open Approach - XRGJ0CA
Fusion Ankle Joint, Left to New Technology Group 9 with Internal Fixation Device, Open-truss Design, Open Approach - XRGK0B9
Fusion Ankle Joint, Left to New Technology Group 10 with Internal Fixation Device, Gyroid-Sheet Lattice Design, Open Approach - XRGK0CA
Fusion Tarsal Joint, Right to New Technology Group 9 with Internal Fixation Device, Open-truss Design, Open Approach - XRGL0B9
Fusion Tarsal Joint, Right to New Technology Group 10 with Internal Fixation Device, Gyroid-Sheet Lattice Design, Open Approach - XRGL0CA
Fusion Tarsal Joint, Left to New Technology Group 9 with Internal Fixation Device, Open-truss Design, Open Approach - XRGM0B9
Fusion Tarsal Joint, Left to New Technology Group 10 with Internal Fixation Device, Gyroid-Sheet Lattice Design, Open Approach - XRGM0CA
Insertion Thoracic Vertebral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Open Approach - XRH60FA
Insertion Thoracic Vertebral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Approach - XRH63FA
Insertion Thoracic Vertebral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Endoscopic Approach - XRH64FA
Insertion Thoracic Vertebral Joints, 2 to 7 to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Open Approach - XRH70FA
Insertion Thoracic Vertebral Joints, 2 to 7 to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Approach - XRH73FA
Insertion Thoracic Vertebral Joints, 2 to 7 to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Endoscopic Approach - XRH74FA
Insertion Thoracic Vertebral Joints, 8 or more to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Open Approach - XRH80FA
Insertion Thoracic Vertebral Joints, 8 or more to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Approach - XRH83FA
Insertion Thoracic Vertebral Joints, 8 or more to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Endoscopic Approach - XRH84FA
Insertion Thoracolumbar Vertebral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Open Approach - XRHA0FA
Insertion Thoracolumbar Vertebral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Approach - XRHA3FA
Insertion Thoracolumbar Vertebral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Endoscopic Approach - XRHA4FA
Insertion Lumbar Vertebral Joint to New Technology Group 8 with Posterior Spinal Motion Preservation Device, Open Approach - XRHB018
Insertion Lumbar Vertebral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Open Approach - XRHB0FA
Insertion Lumbar Vertebral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Approach - XRHB3FA
Insertion Lumbar Vertebral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Endoscopic Approach - XRHB4FA
Insertion Lumbar Vertebral Joints, 2 or more to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Open Approach - XRHC0FA
Insertion Lumbar Vertebral Joints, 2 or more to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Approach - XRHC3FA
Insertion Lumbar Vertebral Joints, 2 or more to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Endoscopic Approach - XRHC4FA
Insertion Lumbosacral Joint to New Technology Group 8 with Posterior Spinal Motion Preservation Device, Open Approach - XRHD018
Insertion Lumbosacral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Open Approach - XRHD0FA
Insertion Lumbosacral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Approach - XRHD3FA
Insertion Lumbosacral Joint to New Technology Group 10 with Carbon/PEEK Spinal Stabilization Device, Pedicle Based, Percutaneous Endoscopic Approach - XRHD4FA
Replacement Knee Joint, Right to New Technology Group 8 with Synthetic Substitute, Lateral Meniscus, Open Approach - XRRG0L8
Replacement Knee Joint, Right to New Technology Group 8 with Synthetic Substitute, Medial Meniscus, Open Approach - XRRG0M8
Replacement Knee Joint, Left to New Technology Group 8 with Synthetic Substitute, Lateral Meniscus, Open Approach - XRRH0L8
Replacement Knee Joint, Left to New Technology Group 8 with Synthetic Substitute, Medial Meniscus, Open Approach - XRRH0M8
Monitoring Kidney to New Technology Group 5 with Fluorescent Pyrazine, External Approach - XT25XE5
Introduction Skin to New Technology Group 7 with Anacaulase-bcdb, External Approach - XW00X27
Introduction Subcutaneous Tissue to New Technology Group 8 with Daratumumab and Hyaluronidase-fihj, Percutaneous Approach - XW01318
Introduction Subcutaneous Tissue to New Technology Group 9 with Talquetamab Antineoplastic, Percutaneous Approach - XW01329
Introduction Subcutaneous Tissue to New Technology Group 8 with Teclistamab Antineoplastic, Percutaneous Approach - XW01348
Introduction Subcutaneous Tissue to New Technology Group 10 with Dasiglucagon, Percutaneous Approach - XW0136A
Introduction Subcutaneous Tissue to New Technology Group 7 with Satralizumab-mwge, Percutaneous Approach - XW01397
Introduction Subcutaneous Tissue to New Technology Group 5 with Other New Technology Therapeutic Substance, Percutaneous Approach - XW013F5
Introduction Subcutaneous Tissue to New Technology Group 6 with REGN-COV2 Monoclonal Antibody, Percutaneous Approach - XW013G6
Introduction Subcutaneous Tissue to New Technology Group 6 with Other New Technology Monoclonal Antibody, Percutaneous Approach - XW013H6
Introduction Subcutaneous Tissue to New Technology Group 6 with Leronlimab Monoclonal Antibody, Percutaneous Approach - XW013K6
Introduction Subcutaneous Tissue to New Technology Group 9 with Elranatamab Antineoplastic, Percutaneous Approach - XW013L9
Introduction Subcutaneous Tissue to New Technology Group 6 with COVID-19 Vaccine Dose 1, Percutaneous Approach - XW013S6
Introduction Subcutaneous Tissue to New Technology Group 9 with Epcoritamab Monoclonal Antibody, Percutaneous Approach - XW013S9
Introduction Subcutaneous Tissue to New Technology Group 6 with COVID-19 Vaccine Dose 2, Percutaneous Approach - XW013T6
Introduction Subcutaneous Tissue to New Technology Group 6 with COVID-19 Vaccine, Percutaneous Approach - XW013U6
Introduction Subcutaneous Tissue to New Technology Group 7 with COVID-19 Vaccine Dose 3, Percutaneous Approach - XW013V7
Introduction Subcutaneous Tissue to New Technology Group 5 with Caplacizumab, Percutaneous Approach - XW013W5
Introduction Subcutaneous Tissue to New Technology Group 7 with COVID-19 Vaccine Booster, Percutaneous Approach - XW013W7
Introduction Subcutaneous Tissue to New Technology Group 7 with Anacaulase-bcdb, External Approach - XW01X27
Introduction Muscle to New Technology Group 8 with Engineered Allogeneic Thymus Tissue, Open Approach - XW020D8
Introduction Muscle to New Technology Group 6 with COVID-19 Vaccine Dose 1, Percutaneous Approach - XW023S6
Introduction Muscle to New Technology Group 6 with COVID-19 Vaccine Dose 2, Percutaneous Approach - XW023T6
Introduction Muscle to New Technology Group 6 with COVID-19 Vaccine, Percutaneous Approach - XW023U6
Introduction Muscle to New Technology Group 7 with COVID-19 Vaccine Dose 3, Percutaneous Approach - XW023V7
Introduction Muscle to New Technology Group 7 with COVID-19 Vaccine Booster, Percutaneous Approach - XW023W7
Introduction Muscle to New Technology Group 7 with Tixagevimab and Cilgavimab Monoclonal Antibody, Percutaneous Approach - XW023X7
Introduction Muscle to New Technology Group 7 with Other New Technology Monoclonal Antibody, Percutaneous Approach - XW023Y7
Introduction Peripheral Vein to New Technology Group 6 with Brexanolone, Percutaneous Approach - XW03306
Introduction Peripheral Vein to New Technology Group 8 with Spesolimab Monoclonal Antibody, Percutaneous Approach - XW03308
Introduction Peripheral Vein to New Technology Group 6 with Nerinitide, Percutaneous Approach - XW03326
Introduction Peripheral Vein to New Technology Group 6 with Durvalumab Antineoplastic, Percutaneous Approach - XW03336
Introduction Peripheral Vein to New Technology Group 10 with Bentracimab, Ticagrelor Reversal Agent, Percutaneous Approach - XW0333A
Introduction Peripheral Vein to New Technology Group 10 with Cefepime-taniborbactam Anti-infective, Percutaneous Approach - XW0334A
Introduction Peripheral Vein to New Technology Group 7 with Narsoplimab Monoclonal Antibody, Percutaneous Approach - XW03357
Introduction Peripheral Vein to New Technology Group 8 with Mosunetuzumab Antineoplastic, Percutaneous Approach - XW03358
Introduction Peripheral Vein to New Technology Group 10 with Ceftobiprole Medocaril Anti-infective, Percutaneous Approach - XW0335A
Introduction Peripheral Vein to New Technology Group 6 with Lefamulin Anti-infective, Percutaneous Approach - XW03366
Introduction Peripheral Vein to New Technology Group 7 with Terlipressin, Percutaneous Approach - XW03367
Introduction Peripheral Vein to New Technology Group 8 with Afamitresgene Autoleucel Immunotherapy, Percutaneous Approach - XW03368
Introduction Peripheral Vein to New Technology Group 2 with Coagulation Factor Xa, Inactivated, Percutaneous Approach - XW03372
Introduction Peripheral Vein to New Technology Group 7 with Trilaciclib, Percutaneous Approach - XW03377
Introduction Peripheral Vein to New Technology Group 8 with Tabelecleucel Immunotherapy, Percutaneous Approach - XW03378
Introduction Peripheral Vein to New Technology Group 7 with Lurbinectedin, Percutaneous Approach - XW03387
Introduction Peripheral Vein to New Technology Group 8 with Treosulfan, Percutaneous Approach - XW03388
Introduction Peripheral Vein to New Technology Group 10 with Obecabtagene Autoleucel, Percutaneous Approach - XW0338A
Introduction Peripheral Vein to New Technology Group 6 with Ceftolozane/Tazobactam Anti-infective, Percutaneous Approach - XW03396
Introduction Peripheral Vein to New Technology Group 8 with Inebilizumab-cdon, Percutaneous Approach - XW03398
Introduction Peripheral Vein to New Technology Group 10 with Odronextamab Antineoplastic, Percutaneous Approach - XW0339A
Introduction Peripheral Vein to New Technology Group 6 with Cefiderocol Anti-infective, Percutaneous Approach - XW033A6
